New Study Concludes That Genetic Testing Is Not as Final as We ThoughtAllbiopro2018-10-31T10:18:24+09:0010월 31st, 2018|
Study: Excessive Daytime Sleepiness Linked to Alzheimer’s DiseaseAllbiopro2018-10-31T10:17:42+09:0010월 31st, 2018|
Genmab and Johnson & Johnson’s Darzalex Dazzles in Multiple Myeloma TrialAllbiopro2018-10-31T10:17:16+09:0010월 31st, 2018|
Gottlieb Says… The FDA Commissioner’s Most Recent StatementsAllbiopro2018-10-31T10:16:51+09:0010월 31st, 2018|
Janssen, Gilead Showcase HIV Data at Glasgow ConferenceAllbiopro2018-10-31T10:16:25+09:0010월 31st, 2018|
AstraZeneca Divests Two Drugs to Grünenthal in $90 Million DealAllbiopro2018-10-31T10:16:01+09:0010월 31st, 2018|
Four Former Genentech Employees Indicted on Theft of Trade SecretsAllbiopro2018-10-31T10:15:34+09:0010월 31st, 2018|
NHLBI Halts Heart Failure Study After Retracted Papers Raise Concern Over Controversial Stem Cell TherapyAllbiopro2018-10-31T10:15:08+09:0010월 31st, 2018|
As It Focuses on Cutting-Edge Therapies, Novartis Cuts 20% of Research ProgramsAllbiopro2018-10-31T10:14:42+09:0010월 31st, 2018|
Pfizer manufacturing ills mean ongoing shortages for hospitalsAllbiopro2018-10-31T10:14:15+09:0010월 31st, 2018|
Amgen, Roche and Regeneron set to suffer biggest hits from Trump pricing plan: reportAllbiopro2018-10-31T10:13:34+09:0010월 31st, 2018|
Allergan beats on Botox boost, but can migraine sales withstand CGRP rivals?Allbiopro2018-10-31T10:13:07+09:0010월 31st, 2018|
AstraZeneca gins up $815M in rights deal for Nexium, VimovoAllbiopro2018-10-31T10:12:40+09:0010월 31st, 2018|
Forget megadeals, Pfizer CEO-to-be Bourla says. They’re just too distractingAllbiopro2018-10-31T10:12:14+09:0010월 31st, 2018|
Genentech staff ‘funneled secrets to Taiwan biosimilar firm,’ prosecutors sayAllbiopro2018-10-31T10:11:46+09:0010월 31st, 2018|
Novartis dumps 20% of programs following pipeline review Allbiopro2018-10-31T10:11:18+09:0010월 31st, 2018|
Biocon investing $200m into second MAb plant in IndiaAllbiopro2018-10-31T10:10:24+09:0010월 31st, 2018|
